Aisling Capital Partners III LP, Director, 10% Owner at AGILE THERAPEUTICS INC (AGRX), bought 811,966 shares at $5.85 ($4.8M) on 2015-01-23, disclosed to the SEC on 2015-01-27.
Open-market purchase of $4.8M AGRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| VSAR | BUY | 2014-03-27 | $1.3M | — | Filing → |
| ZLTQ | SELL | 2013-11-15 | $7.0M | — | Filing → |